Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Humoral Immune Responses01:36

Humoral Immune Responses

73.3K
Overview
73.3K
Antibody Actions01:26

Antibody Actions

1.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Corrigendum to "The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing antibodies". [Virol. 509 [2017] 185-194].

Virology·2026
Same author

Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretins.

Trends in biotechnology·2026
Same author

Efficient in vivo assembly of DNA encoded polyvalent BTEs for dual antigen targeting for broadening therapeutic impact in ovarian cancer.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccination.

iScience·2026
Same author

Deep mining of the human antibody repertoire identifies frequent and genetically diverse CDRH3 topologies targetable by vaccination.

Proceedings of the National Academy of Sciences of the United States of America·2026

相关实验视频

Updated: Jul 28, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.9K

用于广泛中和抗体的输送平台.

Lok R Joshi1, Nicolás M S Gálvez1, Sukanya Ghosh2

  • 1Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.

Current opinion in HIV and AIDS
|June 2, 2023
PubMed
概括

基于基因的广泛中和抗体 (bNAbs) 提供了一个有希望的替代方案,用于预防和治疗艾滋病毒的被动抗体管理. 在DNA,mRNA和病毒载体技术的进步正在克服有效的HIV干预措施的局限性.

科学领域:

  • 免疫学和病毒学
  • 基因治疗和生物技术

背景情况:

更多相关视频

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.5K
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

13.8K

相关实验视频

Last Updated: Jul 28, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.9K
Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.5K
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

13.8K
  • 广泛中和抗体 (bNAbs) 的被动管理是预防和治疗艾滋病毒的一种策略.
  • 目前被动转移的挑战包括需要定期管理.
  • 基于基因的传递方法正在开发中,以克服这些局限性.

结论:

  • 基于基因的bNAbs的输送对艾滋病毒治疗和预防具有重大潜力.
  • 基因传递效率和降低免疫性方面的进一步进展对于广泛实施至关重要.
  • 克服基因bNAb传递的技术挑战,为实现实际的艾滋病毒干预提供了明确的途径.